Last reviewed · How we verify

CHLORHEXIDINE GLUCONATE

FDA-approved withdrawn Small molecule Quality 15/100

Chlorhexidine Gluconate is a marketed antiseptic solution primarily used for healthcare personnel hand hygiene, holding a significant position in infection control protocols. Its key strength lies in its broad-spectrum antimicrobial activity and residual effect, which enhances patient safety and reduces healthcare-associated infections. The primary risk to its market position is the expiration of the key composition patent in 2028, potentially leading to increased competition from generic alternatives.

At a glance

Generic nameCHLORHEXIDINE GLUCONATE
ModalitySmall molecule
PhaseFDA-approved
First approval1976

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: